HUMANIN 10 MG

Humanin 10 mg – Peptide Hubs

Humanin is a mitochondrial-derived peptide (MDP) composed of 24 amino acids, discovered in the brain and muscle tissue. It plays a vital role in cellular protection, oxidative stress regulation, and age-related decline mitigation. Humanin has gained attention in longevity and neurodegeneration research for its unique cytoprotective signaling properties. Peptide Hubs offers Humanin in a 10 mg lyophilized vial, manufactured to research-grade quality standards.

Mechanism of Action

Humanin binds to specific receptors such as FPRL1 and IL-6-type receptors, modulating intracellular stress responses and apoptosis. It protects neurons, muscle cells, and endothelial tissue from oxidative damage and inflammation. Studies also suggest it enhances insulin sensitivity and supports mitochondrial biogenesis. For foundational insights, refer to this NIH review on Humanin's role in mitochondrial signaling.

Primary Research Applications

• Neuroprotection and Alzheimer's disease models
• Cardiovascular aging and endothelial repair studies
• Mitochondrial dysfunction and cellular stress models
• Longevity and anti-aging protocols

Researchers exploring synergy often combine Humanin with GHK Basic for tissue regeneration or DSIP for cognitive and sleep-related studies. When investigating senolytic or aging interventions, it may also complement FOX04-DRI or GHRP-2 in mitochondrial restoration protocols.

Suggested Experimental Use

• Dosage: 1–10 mg weekly, divided across several micro-doses
• Administration: Subcutaneous or intraperitoneal injection
• Duration: 2–12 weeks depending on the research model

Stacking Options

• FOX04-DRI – for mitochondrial senescence-clearing studies
• Chonluten – for immune-cognitive modulation under aging conditions
• B7-33 – to explore fibrosis reduction and vascular remodeling
• Cardiogen – for myocardial repair and oxidative stress reduction

Safety & Legal Status

Humanin is **not FDA-approved** and is strictly for **laboratory research use only**. It has demonstrated a favorable safety profile in preclinical models with no reported toxicity, androgenic activity, or hormonal interference. Humanin does not aromatize or elevate prolactin levels. For the latest trials and molecular pathways, consult ClinicalTrials.gov.

Frequently Asked Questions